Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Masco Insider Sold Shares Worth $2,779,768, According to a Recent SEC Filing

Masco Insider Sold Shares Worth $2,779,768, According to a Recent SEC Filing

MT newswireMT newswire2026/11/03 20:27
04:27 PM EST, 11/03/2026 (MT Newswires) -- Kenneth G. Cole, Vice President, General Counsel and Secretary, on October 30, 2026, sold 34,470 shares in Masco (MAS) for $2,779,768. Following the Form 4 filing with the SEC, Cole has control over a total of 49,700 common shares of the company, with 39,700 shares held directly and 10,000 controlled indirectly. SEC Filing: https://www.sec.gov/Archives/edgar/data/62996/000122520826008617/xslF345X05/doc4.xml
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Dental treatment company vVardis has announced the terms for its $214 million US IPO.

智通财经•2026/11/09 06:41
"No-drill dental filling" company vVardis (VVVV.US) launches a $214 million US IPO, scheduled to be priced this week.

Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss

Novo Nordisk reports that some patients treated with Wegovy have shown improvements in liver conditions.

智通财经•2026/11/09 06:41
Wegovy improves multiple liver indicators in non-obese liver disease patients, and Novo Nordisk (NVO.US) is expected to expand its market beyond weight loss